'Cochlear Implant for Blindness' Debuts in Europe, Could Launch in U.S. in 2027

Science Corporation has announced the European launch of a groundbreaking retinal implant designed for patients with age-related macular degeneration (AMD), a leading cause of vision loss in older adults. Often compared to a 'cochlear implant for blindness,' this innovative device aims to restore functional vision by stimulating the retina directly. The technology could become available in the United States as early as 2027, offering new hope for millions suffering from AMD. This development represents a significant advancement in treating one of the most common causes of irreversible blindness in developed nations.

Originally published on
STAT News
By O. Rose Broderick
Read full article(opens in new tab)Fetched: July 22, 2026 at 10:01 AM



